0.6901
price up icon0.09%   0.0006
after-market Dopo l'orario di chiusura: .68 -0.0101 -1.46%
loading
Precedente Chiudi:
$0.6895
Aprire:
$0.69
Volume 24 ore:
326.57K
Relative Volume:
0.30
Capitalizzazione di mercato:
$35.73M
Reddito:
-
Utile/perdita netta:
$-81.22M
Rapporto P/E:
-0.2331
EPS:
-2.96
Flusso di cassa netto:
$-74.41M
1 W Prestazione:
-4.81%
1M Prestazione:
+4.50%
6M Prestazione:
-15.85%
1 anno Prestazione:
-26.21%
Intervallo 1D:
Value
$0.6801
$0.6962
Intervallo di 1 settimana:
Value
$0.6619
$0.75
Portata 52W:
Value
$0.62
$1.70

Xilio Therapeutics Inc Stock (XLO) Company Profile

Name
Nome
Xilio Therapeutics Inc
Name
Telefono
617-833-1027
Name
Indirizzo
828 WINTER STREET, WALTHAM
Name
Dipendente
73
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-09
Name
Ultimi documenti SEC
Name
XLO's Discussions on Twitter

Confronta XLO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XLO
Xilio Therapeutics Inc
0.6901 35.70M 0 -81.22M -74.41M -2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Xilio Therapeutics Inc Stock (XLO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-12-21 Iniziato Chardan Capital Markets Buy
2022-01-10 Iniziato H.C. Wainwright Buy
2021-11-16 Iniziato Cowen Outperform
2021-11-16 Iniziato Guggenheim Buy
2021-11-16 Iniziato Morgan Stanley Overweight
2021-11-16 Iniziato Raymond James Outperform
Mostra tutto

Xilio Therapeutics Inc Borsa (XLO) Ultime notizie

pulisher
Jul 24, 2025

Does Xilio Therapeutics Inc. stock pay reliable dividendsRecord-breaking gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What risks could impact Xilio Therapeutics Inc. stock performanceDouble-digit growth - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What makes Xilio Therapeutics Inc. stock attractive to long term investorsRapid wealth accumulation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Xilio Therapeutics Inc. stockExplosive market performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Xilio Therapeutics Inc. Stock Analysis and ForecastLightning-fast growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Xilio Therapeutics Inc. a good long term investmentOverwhelming profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Xilio Therapeutics Inc. stock priceHigh-return market picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Xilio Therapeutics Inc. stock price move sharplyFree Best Stocks to Buy Today - Newser

Jul 22, 2025
pulisher
Jul 18, 2025

What analysts say about Xilio Therapeutics Inc. stock outlookFree Step-by-Step Investment Guide - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

Why Xilio Therapeutics Inc. stock attracts strong analyst attentionVerified Return Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Xilio Therapeutics Inc. stock performs during market volatilityFree Deep Market Trend Analysis - Newser

Jul 15, 2025
pulisher
Jul 03, 2025

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 03, 2025
pulisher
Jul 02, 2025

Xilio Therapeutics Awards $7,400 in Stock Options to Strategic New Employees - Stock Titan

Jul 02, 2025
pulisher
Jun 18, 2025

Xilio Therapeutics Executives Increase Holdings - TradingView

Jun 18, 2025
pulisher
Jun 16, 2025

Xilio Therapeutics, Inc. (NASDAQ:XLO) Short Interest Update - Defense World

Jun 16, 2025
pulisher
Jun 12, 2025

Xilio Therapeutics Expands Authorized Shares at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 11, 2025

Xilio Therapeutics Appoints Akintunde Bello to Board of Directors - citybiz

Jun 11, 2025
pulisher
Jun 10, 2025

Xilio Therapeutics appoints oncology veteran Akintunde Bello to board By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Xilio Therapeutics expands board, elects new director - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

Xilio Therapeutics expands board, elects new director By Investing.com - Investing.com South Africa

Jun 10, 2025

Xilio Therapeutics Inc Azioni (XLO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):